Skip to main content

The efficacy of the 4-hook needle localization for pulmonary ground glass nodules: a single-center retrospective analysis

Abstract

Introduction

The aim of this study was to evaluate the efficacy of the 4-hook needle localization for pulmonary ground glass nodules (GGNs).

Methods

From November 1, 2021, to May 31, 2024, 194 patients were diagnosed with one or more GGNs by computed tomography (CT) scan and underwent preoperative CT-guided 4-hook needle localization followed by video-assisted thoracoscope surgery (VATS) wedge resection, segmentectomy or lobectomy. There were 226 nodules in all patients. We analyzed the 4-hook needle localization safety, complications, safe margin and localization depth.

Results

The 4-hook needle localizations success rate was 100% and didn't take place in displacement and dislodgment. The tumor margin distance is about 5–20 mm and all tumor margin was negative thorough final pathology result. 9 patients occurred small parenchymal hemorrhage, 13 patients occurred small pneumothorax and 8 patients occurred small hemoptysis, those complications needn't intervene or tackle and didn't affect surgery. Compared upper and middle lobe to lower lobe, localization time was 13.92 ± 4.6 min vs 13.66 ± 4.28 min respectively, p = 0.69, there was no significant statistical difference. Localization depth was 18.63 ± 7.8 mm vs 15.87 ± 8.52 mm respectively, p = 0.02, there were statistical differences, but the margin tumor distance was 5.16 ± 4.94 mm vs 4.93 ± 3.64 mm, p = 0.73 respectively, there was no statistical difference.

Conclusions

Preoperative 4-hook needle localization is safe and feasible for GGNs. Guided by 4-hook needle localization, wedge resection can ensure enough safe margins and patient was well tolerated.

Peer Review reports

Introduction

Lung cancer is the leading cause of deaths among cancer patients around the world [1]. The detection rate of GGNs has increased year by year, especially in young people or female non-smoking, has a high proportion of malignances [2, 3]. The malignant proportion of GGNs accounted for a rate of 87.2% [4]. Although GGNs as an indolent subtype of lung adenocarcinoma, it requires special management [5].

Malignant GGNs are important to regular follow up or intervention, earlier intervention as an active method can improve survival rates, surgical treatment is the first choice [6]. Fu et al. illustrated that the 5-year recurrence-free survival (RFS) with purify GGNs (pGGNs) and mix GGNs (mGGNs), stage I was 100% VS 87.6% [7]. Atypical adenomatous hyperplasia(AAH), carcinoma in situ(AIS), minimally invasive adenocarcinoma(MIA) were classified together as a low-risk group, the 5-year RFS rate was also 100% [8]. Tsutani et al. reported patients with clinical stage IA lung adenocarcinoma with more than 50% GGNs component, there was no statistically differences in 3-year RFS undergoing lobectomy (96.4%), segmentectomy (96.1%), or wedge resection (98.7%) [9]. The 5-year RFS rate of partial lung resection for GGN dominant lesions with a consolidation tumor ratio < 0.25 was 99.7% [10]. Wedge resection is suitable for the most patients with GGNs and is curative [11].

GGNs depend on direct visualization or palpation intraoperative in past. Small, purify or deep GGNs are often difficult to palpate or identify during VATS, which extends operation time and increase normal lung tissue damage. Moreover, the safety margin of GGNs can’t be accurately predicted and even miss GGNs [12, 13]. Surgery needs to remove little lung tissue and doesn't shorten RFS and overall survival (OS). At present, preoperative CT-guided localization is a good choice, 4-hook needle as a novel GGNs localization device, has been reported in clinical studies [14].The aim of this study was to evaluate the efficacy of the 4-hook needle localization in patients with VATS.

Materials and methods

This retrospective study was performed in accordance with the principles outlined in the Declaration of Helsinki and approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-Sen University (No. II2024-094–01). Informed consent was obtained from all patients before preoperative 4-hook needle localization as well as the utilization of their personal data. The study was received approval.

Patients and inclusion criteria

This was a single-center retrospective study. From November 1, 2021, to May 31, 2024, data from 194 patients who were diagnosed with one or more GGNs by CT scan, all GGNs for localization and resection were suspicious for malignancy at first. There were 226 nodules in all patients. we collected all patients' materials via the electronic medical record system in the third affiliated hospital of Sun Yat-Sen University.

The eligible criteria for GGNs wedge resection included in: (I) GGNs with a maximum transverse diameter of ≥ 8 mm but ≤ 20 mm, and with a solid component < 5 mm or solid part is < 20%; According to the current agreements and 2023 guideline from the American Cancer Society, diameter of ≥ 8 mm GGN can be treated with surgery, and smaller GGN should be regular follow-up [15]. (II) enlargement or density increase of GGNs during regular follow-up by CT scan; (III) isolated lung metastasis when the primary tumor was cured or well controlled; (IV) ipsilateral multiple nodules which was same suspected to be malignant and < 8 mm in size, were synchronously localized and resected, and (V) the depth from pleural of GGNs is ≤ 30 mm. The CT parameters of nodules were examined in lung window settings (window level: − 500 HU, window width: 1500 HU) by two researchers. Clinical characteristics are shown in Table 1.

Table 1 Clinical characteristics of patients and GGNs

Interventional equipment and localization techniques

A 64-slice helical CT scanner (layer thickness 1.25 mm) was used to guide percutaneous puncture and localization. 4-hook needle with a scaled suture (Sheng Jie Kang Biological Technology Co., Ltd., Ningbo, China) was used for localization. The localization device contains a 4-hook anchor and a tricolored suture with a scale. Anchor can fix in lung tissue and tricolored suture could evaluate the depth of localizations (Fig. 1).

Fig. 1
figure 1

A The 4-hook needle, B The 4-hook anchor and a tricolored suture with a scale

The puncture route was determined by the location and adjacency of nodule and adjusted according to the planned VATS approach. Usually, the puncture route was the shortest distance to the pleura and the least amount of lung tissue traversed as possible. Target position of the 4-hook needle was localized behind or beside the nodule within 10 mm, but not the surface visceral pleura or in front of nodule, then to estimate the depth of nodules. After claw released, the patient was taken a final CT scan to confirm the device position and any complications (Fig. 2). Then patients returned to the ward and underwent the operation next day usually.

Fig. 2
figure 2

Localization nodule: the red arrow; 4-hook needle: the blue arrow; 4-hook needle claw: the green arrow. The procedure for 4-hook needle localization nodule: A: patient is positioned appropriately, and the location of the nodule is determined by CT scan. B: a puncture needle is used for target nodule localization; C: the 4-hook needle claw is released and fixed to lung tissue

Surgical procedure

Patients were placed under general anesthesia via a laryngeal mask, single-lumen endotracheal tube or double-lumen endotracheal tube after the assessment of the anesthesiologist and surgeon. According to difficulty of operation, nodules position, skills of surgeon, the single port or 2-ports VATS was used. Single port about 3 cm in the fourth or fifth intercostal space was made at the anterior axillary line. If 2-ports method, another port about 1 cm in the seventh intercostal space was made at the midaxillary line for the thoracoscope. The patient’s breathing was resumed with a small tidal volume (about 250 ml) and high frequency (about 18 times per minute). When entering the thoracic cavity, patient's breathing was stopped for a little while. The lung tissue was compressed by an oval forceps to make the lung collapsed completely. The tri-colored suture on the surface of the pleura was found easily.

Wedge resection steps were as follows: First, the scale suture was gently lifted to determine the depth of the claw. Second, the visceral pleura and scale suture were pulled by a curved forceps, then an oval forceps (diameter of about 1 cm) was used to evaluate the resection margin. The expected resection margin distance was evaluated by the diameter of nodule, the reading of scale suture and the location relationship between anchor and nodule and was equal to the diameter of nodule at least. Subsequently, the resection margin was marked. Finally, both the nodule and anchor were resected completely with staplers along the marked line (Fig. 3).

Fig. 3
figure 3

Intraoperative VATS showed the tri-colored suture on the surface of the pleura and the 4-hook claw fixed to lung tissue

The specimen was incised along the maximum diameter of nodule and perpendicular to the stapler line, and the resection margin distance, from the nodule’s inner border to the nearest staple line, was measured with a ruler in its natural state and recorded in the surgical record. Then frozen pathologic examination was performed. Complete resection is sufficient if the disease is benign or metastatic, regardless of the resection margin distance. The resection saft margin distance is required to be ≥ 5 mm if the disease is carcinoma in situ or malignant according to the JCOG 0804 study. An expanded wedge resection is required if the resection margin distance is < 5 mm in case of IAC, while segmental or lobectomy is performed if an extended wedge resection is impracticable.

Histopathological evaluations

The tumor margin distance was measured macroscopically which was defined as the shortest width between the resection line. All nodules and the margin tissue were examined by histologically. According to the 2015 World Health Organization (WHO) Classification of Lung Tumors, MIA and AIS were defined as small (≤ 3 cm) solitary adenocarcinomas that exhibited a lepidic growth pattern with ≤ 5 mm invasion (MIA) or without invasion (AIS) respectively.

Main observation indicators

The main indicators include the nodules position, diameter, depth, and the distance between the claw and nodule, localization time, success rate of localization, complications and resection tumor margin distance. The depth of the nodule was defined as the distance between the nearest visceral pleural surface and the nodule’s inner border. Successful localization was defined no dislodgement or displacement. All the indicators were determined and recorded by two researchers after they reached a consensus.

Statistical analysis

SPSS version 20.0 (IBM Corp., Armonk, NY, USA) used for the statistical analyses. Quantitative variables were expressed as a number, median, and range, and categorical variables were described as a number and percentage. The descriptive statistics were presented as mean ± SD. Categorical variables were assessed using Mann–Whitney U tests. A p value < 0.05 was considered to indicate a statistically significant difference.

Results

Baseline statistics

Totally 194 patients (79 male and 115 female; median age, 51 years; age range, 16–81 years) with 226 GGNs were involved, who underwent CT-guided 4-hook needle localization and then carried out wedge resection, segmentectomy or lobectomy with VATS. All 226 nodules were successfully resected with pathological negative margins. pGGNs, mGGNs and sGGNs were 130 nodules,73 nodules and 23 nodules respectively. GGNs diameter was 4–20 mm an margin distance was 5–20 mm. The nodules distance to the pleural surface less than 20 mm were 158 and more than 20 mm were 68. 47 nodules located in left upper lobe, 37 nodules located in left lower lobe, 95 nodules located in right upper lobe, 9 nodules located in right middle lobe and 38 nodules located in right lower lobe. The final pathological diagnosis included in AAH 5 nodules, AIS 51 nodules, MIA 119 nodules, IAC 15 nodules, metastasis tumor 8 nodules and others benign nodules 28. (Table 1).

Localization and surgical procedure outcomes

There were no major complications or deaths perioperative. 57 nodules with the depth of anchor claw were less than 10 mm, 101 nodules were 10 mm and 20 mm; 60 nodules were 20 mm and 30 mm and the other 8 nodules were more the 30 mm. The anchor claw was placed in 4 nodules and around 222 nodules, 174 anchor claws placed within 10 mm around nodules and 48 anchor claws placed more than 10 mm.The localizations success rate was 100%. 168 patients with single nodule, 20 patients with 2 nodules and 6 patients with 3 nodules underwent simultaneous localization and resection.

Complications included parenchymal hemorrhage was 9 patients, asymptomatic pneumothorax was 13 patients and hemoptysis was 8 patients. Those complications were small and needn't special medical intervention. We didn’t use hemostatic drugs or place thoracic drainage, and monitored vital signs. Blood pressure, heart rate and blood oxygen saturation were normal. There was no cases of dislodgement or claw-suture fracture during the entire process. All devices were visualized at the first attempt before VATS resection and retrieved entirely with the resected nodules (Table 2).

Table 2 Outcome of localization and surgery

Compared upper and middle lobe to lower lobe, localization time were 13.92 ± 4.6 min vs 13.66 ± 4.28 min respectively, p = 0.69, there was no statistical difference. Location depth was 18.63 ± 7.8 mm vs 15.87 ± 8.52 mm respectively, p = 0.02, there were statistical differences in two group. The margin safe distance were 5.16 ± 4.94 mm vs 4.93 ± 3.64 mm, p = 0.73, there was no statistical difference between the two groups. Data analysis is shown in Table 3.

Table 3 Data analysis of upper and middle lobe vs lower lobe

Discussion

GGNs between 5–10 mm should performed LDCT in first 6 months followed by annual LDCT for 2 years or resection when developed solid part or increased in size. GGN > 10 mm, LDCT should be done in 3–6 months regular followed by LDCT in 6–12 months or biopsy or resection [4]. GGNs increase anxiety and nervous in most patients, VATS is a major therapy and/or diagnosis method in GGNs which especially first considered the malignances.

Accurate localization for GGNs are an essential step in resection and also avoid unnecessary extensive resections [16]. Hook-wire, coil, indocyanine green (ICG), Virtual-assisted lung mapping (VAL-MAP), ultrasound and 4-hook needle methods were usually used to preoperative or intraoperative localization [17,18,19]. The pneumothorax rate in patients undergoing the Hook-wire localization was the 33–38% rates reported previously [20], resulted in poor experience and more pain. ICG overflow and diffusion in the chest cavity would result in localization failure and multiple GGNs isn’t possible successful. Surgery is required within 3 h after localization, its fluorescence signal has a limited depth and can’t detect deeper GGNs [21]. VAL-MAP as a localization method, its procedure requires multiple steps and is difficult to perform in many hospitals; Second, it isn’t possible to confirm the mapping points preoperatively [22].

4-hook needle as a novel device, which located success rate was 100% and didn't take place in displacement and dislodgment intraoperative. It stays in patient body relatively longer and have lower VAS scores, discomfort and complications, only a few patients need painkiller. The 4-hook needle claw have a strong binding force with the lung tissue and the position is relatively fixed, its posterior connection is a soft line, which can reduce the stimulation of pleura, especially multiple GGNs [13]. Otherwise, operator can obviously palpate or observe the 4-hook needle and easily determine the nodules position by judging the localization.

Localization complications are usual pneumothorax and hemorrhage, including in 9 patients occurred small parenchymal hemorrhage, 13 patients occurred small pneumothorax, 8 patients occurred small hemoptysis, those complications needn't intervene or tackle. The pneumothorax rate is 6.7% in our study, is lower than Hook-wire localization [20]. Those complications don't affect and delay surgery, patients recover successfully and without any new complications or sequelae, which demonstrated that the 4-hook needle method was safe.

GGNs with a diameter < 20 mm could be managed with sublobectomy [23,24,25]. Wedge resection was related to fewer complications, lower risk and preserved more lung tissue [26]. All GGNs were first performed wedge resection. Frozen results indicated 15 patients with IAC, which 10 patients didn't perform lobectomy or segmentectomy due to poor lung function and 5 patients underwent lobectomy or segmentectomy. IAC with margins < 5 mm, we performed lobectomy or segmentectomy for patients according to diameter, consolidation-to-tumor ratio (C/T) and lung function. JCOG0802/WJOG4607L showed that peripheral GGNs with a diameter ≤ 2 cm improved OS after segmentectomy compared with lobectomy [27]. GGNs with a diameter > 3 cm performed lobectomy [28].

Enough margin distance plays a role in wedge resection, which contributes to survival and recurrence for early NSCLC. Wolf et al. found that the tumor margin distance > 9 mm was associated with the improved RFS, and tumor margin distance > 11 mm was associated with improved OS [29].The tumor margin distance is 5–20 mm in our study. Operator can better locate the tumor margin distance by the 4-hook needle mark. The margin was negative in all patients thorough final pathology result.

Compared upper and middle lobe to lower lobe, location depth was statistical differences, but margin distance was no statistical difference in two group. On the one hand, the nodules of lower lobe are perhaps close to the pleura; on the other hand, due to the influence of breathing, lower lobe has large motion and the localization isn’t deep. No matter the nodule location, the 4-hook needle can guide surgery, ensure to resect all nodules successfully and have enough negative margin.

Multiple GGNs are becoming more and common, which are usually considered multiple primary lung carcinomas [30]. All 20 patients with 2 nodules and 6 patients with 3 nodules underwent simultaneous localization and resection. Multiple nodules localizations can reduce stimulation of pleura and decrease the incidence of pneumothorax and hemorrhage by the 4-hook needle. Otherwise, one nodule removed first and the other nodules are difficult to locate due to anatomical changes in the same lobe, 4-hook needle localization can help to remove the target nodules and preserve more lung tissue. For patients with 2 or 3 GGNs, the localization time in every GGNs was almost the same as the single-nodule, those patients’ complication rates weren’t higher than the single-nodule localizations.

Nodule location deeper than 30 mm from the pleura, although the 4-hook need localization, it is difficult to perform wedge resection in some lung lobe, which doesn’t ensure enough margins, deep GGNs usually perform segmentectomy or lobectomy. In older patients with multiple comorbidities and poor lung function, nonsurgical treatment is available for GGNs. Stereotactic body radiotherapy (SBRT) and Radiofrequency ablation (RFA) are alternative treatment as treatment for GGNs [31].

There are some limitations in our study. First, we only admit a small number of patients and this study is a single-center retrospective study, which it lacks large multicenter, randomized controlled trials to support. Second, the longest follow-up time was 2.5 years at present in all patient for malignant GGNs, no one had tumor recurrence and all survived, whether 4-hook needle localization promoting recurrence or metastases needed further follow-up and research.

Conclusion

Preoperative CT-guided 4-hook needle localization for VATS is safety and feasible in GGNs. It can stay in patient body relatively longer, reduce the operation difficulty, improve the success rate and has a low complications rate. Guided by 4-hook needle localization, wedge resection can ensure enough tumor margins. It is a recommended localization method for GGNs.

Availability of data and materials

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Abbreviations

GGN:

Ground glass nodule

CT:

Computed tomography

VATS:

Video-assisted thoracoscope surgery

LDCT:

Low dose CT

HRCT:

High-resolution CT

RFS:

Recurrence-free survival

pGGNs:

Purify GGNs

mGGNs:

Mix GGNs

AAH:

Atypical adenomatous hyperplasia

AIS:

Carcinoma in situ

MIA:

Minimally invasive adenocarcinoma

OS:

Overall survival

IAC:

Invasive adenocarcinoma

ICG:

Indocyanine green

VAL-MAP:

Virtual-assisted lung mapping

SBRT:

Stereotactic body radiotherapy

RFA:

Radiofrequency ablation

References

  1. Xu F, Cai Z, Xu B, Song J, Liu H, Li X, Deng A, Wu X, Chen J. Clinical research on the combined use of systemic chemotherapy and CT-guided radiofrequency ablation in treatment of lung cancer. Lasers Med Sci. 2022;37(1):233–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s10103-020-03222-9.

    Article  PubMed  Google Scholar 

  2. Wang J, Ma H, Ni CJ, He JK, Ma HT, Ge JF. Clinical characteristics and prognosis of ground-glass opacity nodules in young patients. J Thorac Dis. 2019;11(2):557–63. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd.2019.01.32.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ye T, Deng L, Wang S, Xiang J, Zhang Y, Hu H, Sun Y, Li Y, Shen L, Xie L, et al. Lung adenocarcinomas manifesting as radiological part-solid nodules define a special clinical subtype. J Thorac Oncol. 2019;14(4):617–27. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtho.201812.030.

    Article  PubMed  Google Scholar 

  4. Yamaguchi M, Furuya A, Edagawa M, Taguchi K, Shimamatsu S, Toyokawa G, Toyozawa R, Nosaki K, Hirai F, Seto T, et al. How should we manage small focal pure ground-glass opacity nodules on high-resolution computed tomography? A single institute experience. Surg Oncol. 2015;24(3):258–63. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.suronc.2015.08.004.

    Article  PubMed  Google Scholar 

  5. Chang B, Hwang JH, Choi Y-H, Chung MP, Kim H, Kwon OJ, Lee HY, Lee KS, Shim YM, Han J, et al. Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest. 2013;143(1):172–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1738/chest.11-2501.

    Article  PubMed  Google Scholar 

  6. Shimomura M, Inoue M. Therapeutic strategy for lung adenocarcinoma with pure ground-glass opacity: surgery, radiotherapy, or watchful waiting? J Thorac Dis. 2024;16(1):804–6. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd-23-1633.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fu F, Zhang Y, Wen Z, Zheng D, Gao Z, Han H, Deng L, Wang S, Liu Q, Li Y, et al. Distinct prognostic factors in patients with stage I non-small cell lung cancer with radiologic part-solid or solid lesions. J Thorac Oncol. 2019;14(12):2133–42. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtho.2019.08.002.

    Article  PubMed  Google Scholar 

  8. Liu S, Wang R, Zhang Y, Li Y, Cheng C, Pan Y, Xiang J, Zhang Y, Chen H, Sun Y. Precise diagnosis of intraoperative frozen section is an effective method to guide resection strategy for peripheral small-sized lung adenocarcinoma. J Clin Oncol. 2016;34(4):307–13. https://doiorg.publicaciones.saludcastillayleon.es/10.1200/jco.2015.63.4907.

    Article  PubMed  Google Scholar 

  9. Tsutani Y, Miyata Y, Nakayama H, Okumura S, Adachi S, Yoshimura M, Okada M. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma. Chest. 2014;145(1):66–71. https://doiorg.publicaciones.saludcastillayleon.es/10.1378/chest.13-1094.

    Article  PubMed  Google Scholar 

  10. Suzuki K, Watanabe S-I, Wakabayashi M, Saji H, Aokage K, Moriya Y, Yoshino I, Tsuboi M, Nakamura S, Nakamura K, et al. A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer. J Thorac Cardiovasc Surg. 2022;163(1):289-301.e282. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtcvs.2020.09.146.

    Article  PubMed  Google Scholar 

  11. Huang KX, Gibney BC. Pure ground-glass opacities (GGO) lung adenocarcinoma: surgical resection is curative. J Thorac Dis. 2024;16(5):3518–21. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd-23-1983.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zhao G, Yu X, Chen W, Geng G, Li N, Liu H, Yin P, Sun L, Jiang J. Computed tomography-guided preoperative semi-rigid hook-wire localization of small pulmonary nodules: 74 cases report. J Cardiothorac Surg. 2019. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-019-0958-z.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wang Y, Jing L, Liang C, Liu J, Wang S, Wang G. Comparison of the safety and effectiveness of the four-hook needle and hook wire for the preoperative positioning of localization ground glass nodules. J Cardiothorac Surg. 2024;19(1):35. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-024-02497-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Wu W, Li X, Wu Y, Zhang K, Xu J, Zhang J, Chen H. A novel localization device for small pulmonary nodules in thoracoscopic wedge resection with adequate margin distance: a retrospective study. J Thorac Dis. 2023;15(12):6515–24. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd-23-871.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wolf AMD, Oeffinger KC, Shih TYC, Walter LC, Church TR, Fontham ETH, Elkin EB, Etzioni RD, Guerra CE, Perkins RB, et al. Screening for lung cancer: 2023 guideline update from the American cancer society. CA: Cancer J Clin. 2023;74(1):50–81. https://doiorg.publicaciones.saludcastillayleon.es/10.3322/caac.21811.

    Article  PubMed  Google Scholar 

  16. Song X, Li J, Wang D. A hook wire sliding into pulmonary artery and being extracted under DSA: a case report about a rare complication associated with lung nodule localization. J Cardiothorac Surg. 2020. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-020-01105-2.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Park CH, Lee SM, Lee JW, Hwang SH, Kwon W, Han K, Hur J, Park CH, Lee SM, Lee JW, et al. Hook-wire localization versus lipiodol localization for patients with pulmonary lesions having ground-glass opacity. J Thorac Cardiovasc Surg. 2020;159(4):1571-1579.e1572. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtcvs.2019.08.100.

    Article  CAS  PubMed  Google Scholar 

  18. Fang H-Y, Chang K-W, Chao Y-K. Hybrid operating room for the intraoperative CT-guided localization of pulmonary nodules. Annals Transl Med. 2019;7(2):34–34. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/atm.2018.12.48.

    Article  Google Scholar 

  19. Su T-H, Fan Y-F, Jin L, He W, Hu L-B. CT-guided localization of small pulmonary nodules using adjacent microcoil implantation prior to video-assisted thoracoscopic surgical resection. Eur Radiol. 2015;25(9):2627–33. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00330-015-3676-5.

    Article  PubMed  Google Scholar 

  20. Lin J, Wang L-F, Wu A-L, Teng F, Xian Y-T, Han R. Preoperative lung nodule localization: comparison of hook-wire and indocyanine green. Videosurg Other Miniinvasive Tech. 2022. https://doiorg.publicaciones.saludcastillayleon.es/10.5114/wiitm.2022.119767.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Dai B, Yu A, Zhao G, Wang Y, Zhou Y, Ni K. Advantages and rational application of indocyanine green fluorescence in pulmonary nodule surgery: a narrative review. J Thorac Dis. 2024;16(10):7192–203. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd-24-1502.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Kuwata T, Shinohara S, Matsumiya H, Takenaka M, Oka S, Chikaishi Y, Hirai A, Imanishi N, Kuroda K, Tanaka F. Virtual-assisted lung mapping (VAL-MAP) shortened surgical time of wedge resection. J Thorac Dis. 2018;10(3):1842–9. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd.2018.03.12.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Niimi T, Samejima J, Wakabayashi M, Miyoshi T, Tane K, Aokage K, Taki T, Nakai T, Ishii G, Kikuchi A, et al. Ten-year follow-up outcomes of limited resection trial for radiologically less-invasive lung cancer. Jpn J Clin Oncol. 2024;54(4):479–88. https://doiorg.publicaciones.saludcastillayleon.es/10.1093/jjco/hyad187.

    Article  PubMed  Google Scholar 

  24. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman JR, Bharat A, Bruno DS, Chang JY, Chirieac LR, D’Amico TA, et al. Non-small cell lung cancer, version 3.2022, NCCN. Clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2022;20(5):497–530. https://doiorg.publicaciones.saludcastillayleon.es/10.6004/jnccn.2022.0025.

    Article  Google Scholar 

  25. Bertolaccini L, Cara A, Chiari M, Diotti C, Glick N, Mohamed S, Uslenghi C, Mazzella A, Brambilla D, Bertolotti R, et al. Real-world survival outcomes of wedge resection versus lobectomy for cT1a/b cN0 cM0 non-small cell lung cancer: a single center retrospective analysis. Front Oncology. 2023. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fonc.2023.1226429.

    Article  Google Scholar 

  26. Bian D, Xiong Y, Jin K, Zhu Y, Yu H, Dai J, Jiang G. The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center. J Thorac Dis. 2023;15(1):54–64. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/jtd-22-1010.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, et al. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial. Lancet. 2022;399(10335):1607–17. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/s0140-6736(21)02333-3.

    Article  CAS  PubMed  Google Scholar 

  28. Kim YT. Management of ground-glass nodules: when and how to operate? Cancers. 2022;14(3):715. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/cancers14030715.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wolf AS, Swanson SJ, Yip R, Liu B, Tarras ES, Yankelevitz DF, Henschke CI, Taioli E, Flores RM. The impact of margins on outcomes after wedge resection for stage I non-small cell lung cancer. Ann Thorac Surg. 2017;104(4):1171–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.athoracsur.2017.04.024.

    Article  PubMed  Google Scholar 

  30. Qu R, Tu D, Hu S, Wang Q, Ping W, Hao Z, Cai Y, Zhang N, Wang J, Fu X. Electromagnetic navigation bronchoscopy-guided microwave ablation combined with uniportal video-assisted thoracoscopic surgery for multiple ground glass opacities. Annals Thorac Surg. 2022;113(4):1307–15. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.athoracsur.2021.04.061.

    Article  Google Scholar 

  31. Kim B-G, Um S-W. A narrative review of the clinical approach to subsolid pulmonary nodules. Annals Transl Med. 2023;11(5):217–217. https://doiorg.publicaciones.saludcastillayleon.es/10.21037/atm-22-5246.

    Article  Google Scholar 

Download references

Acknowledgements

No

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

ZJ and CHG designed this work. WYH, ZK and XJN collected the clinical data. HYH performed the statistical analyses. WYH wrote this article. Final manuscript was approved by all authors.

Corresponding author

Correspondence to Huiguo Chen.

Ethics declarations

Ethics approval

This retrospective study was performed in accordance with the principles outlined in the Declaration of Helsinki and approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-Sen University (No. II2024-094–01). Informed consent was obtained from all patients before preoperative 4-hook needle localization as well as the utilization of their personal data. The study was received approval.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wu, Y., Xu, J., Zhang, K. et al. The efficacy of the 4-hook needle localization for pulmonary ground glass nodules: a single-center retrospective analysis. J Cardiothorac Surg 20, 146 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-025-03371-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s13019-025-03371-4

Keywords